Skip to content
ClinCalc Pro
Menu
Vaccine

Cholera vaccine (live attenuated, oral)

Brand names: Vaxchora

This is a single-dose oral live attenuated cholera vaccine derived from a genetically modified V. cholerae O1 strain, used for active immunisation of adult travellers against cholera caused by serogroup O1.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

The attenuated organism transiently colonises the gut and induces a mucosal and systemic antibody response against V. cholerae O1 without producing active cholera toxin.

Prescribing in practice

  • As a live vaccine it should generally be avoided in significantly immunocompromised patients and in pregnancy unless the benefit clearly outweighs the risk.
  • It is reconstituted with the supplied buffer and taken on an empty stomach, avoiding food and drink around the dose.
  • Vaccine organisms can be shed in the stool for a period, so attention to hand hygiene reduces any theoretical transmission to close contacts, and it does not protect against the O139 serogroup.

Monitoring

No routine laboratory monitoring is required; observe for immediate hypersensitivity after dosing.

Counselling the patient

  • Take the single dose on an empty stomach and avoid food and drink for the recommended period around it.
  • Wash hands carefully after using the toilet for several days, and continue normal food and water precautions abroad.

Evidence & guidelines

Single-dose live attenuated oral cholera vaccine is supported by controlled human challenge and immunogenicity data summarised in its SPC and travel-health guidance.

Reference: UK Green Book; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.